Mmtec Inc is a software-application business based in the US. Mmtec shares (MTC) are listed on the NASDAQ and all prices are listed in US Dollars. Mmtec employs 31 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Active traders
Our top pick for
Beginners
Our top pick for
Building a portfolio
| Latest market close | $0.67 |
|---|---|
| 52-week range | $0.57 - $5.94 |
| 50-day moving average | $1.17 |
| 200-day moving average | $1.52 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.20 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.672 from 2022-01-14
| 1 week (2022-01-10) | 10.16% |
|---|---|
| 1 month (2021-12-17) | -24.92% |
| 3 months (2021-10-15) | -50.22% |
| 6 months (2021-07-16) | -59.27% |
| 1 year (2021-01-15) | -65.71% |
|---|---|
| 2 years (2020-01-17) | -71.40% |
| 3 years (2019-01-17) | 6.11 |
| 5 years (2017-01-13) | N/A |
| Revenue TTM | $920,103 |
|---|---|
| Gross profit TTM | $734,720 |
| Return on assets TTM | -24.16% |
| Return on equity TTM | -48.51% |
| Profit margin | 0% |
| Book value | $0.60 |
| Market capitalisation | $15.3 million |
TTM: trailing 12 months
We're not expecting Mmtec to pay a dividend over the next 12 months.
Over the last 12 months, Mmtec's shares have ranged in value from as little as $0.5696 up to $5.94. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mmtec's is 3.7138. This would suggest that Mmtec's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Mmtec, Inc. , together with its subsidiaries, develops and deploys platforms that enable financial institutions to engage in securities market transactions and settlements in the People's Republic of China. The company operates in two segments, Gujia and MM Global Capital, and MM Global. It offers Internet-based securities solutions comprising Securities Dealers Trading System, such as securities registration and clearing, account management, risk management, trading and execution, and third party access middleware; Private Fund Investment Management System that supports multi-account management, fund valuation, risk management, quantitative trading access, liquidation, and requisition management; and Mobile Transaction Individual Client System and PC Client System for Apple IOS, Android, PC, and Web. The company enables its customers to white label its trading interface, as well as select modular functionalities. It serves hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms. The company was founded in 2015 and is headquartered in Beijing, the People's Republic of China.
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.